We DO NOT PROVIDE ANY PRODUCTS OR SERVICES DIRECTLY TO PATIENTS. All of our products are for Research Use Only (RUO), NOT intended for diagnostic, therapeutic, or clinical use.
A17L, a viral envelope protein, is a core structural component critical to the assembly and release of the Monkeypox virus. As a key player in the morphogenesis of the viral envelope, A17L is indispensable for viral replication and infectivity. The A17L protein plays a critical role in the lifecycle of the Monkeypox virus (MPXV), making it an essential target for research aimed at understanding viral mechanisms and developing tools for diagnostic and analytical applications. Leveraging over years of expertise in antibody development, Creative Biolabs is a trusted provider of comprehensive A17L-specific antibody development services.
Creative Biolabs offers a range of A17L-specific antibody development services designed to address various research needs. Our comprehensive workflow integrates state-of-the-art platforms, proprietary technologies, and experienced scientists to ensure optimal outcomes.
Our services include the generation of monoclonal and polyclonal antibodies against A17L using diverse platforms such as hybridoma, phage display, and single B-cell screening.
For applications requiring enhanced antibody properties, Creative Biolabs excels in engineering solutions:
Once validated, our platform supports scalable production of A17L antibodies, ensuring consistent quality for further analysis or application.
A17L is critical for the formation and stability of the viral envelope, contributing to the structural integrity of the virion. During viral morphogenesis, A17L interacts with other viral proteins to mediate the budding and assembly processes required for the generation of infectious viral particles.
A17L has been implicated in evading host immune responses by masking viral components or influencing the trafficking of immune-modulatory proteins. These functions highlight the importance of A17L as a research target for understanding MPXV pathogenesis.
| Cat# | Product Name | Target | Antibody Isotype | Species Reactivity | Applications |
|---|---|---|---|---|---|
| MPYF-1122-KX1630 | Anti-Squirrel Parapoxvirus A17L Monoclonal Antibody (MP-K2430) (Mouse IgG) | A17L | Mouse IgG | Squirrel Parapoxvirus | WB (Other applications need to be tested) |
| MPYF-1022-KX1642 | Anti-Variola (Smallpox) Virus A17L Monoclonal Antibody (MP-K1576) (Mouse IgG) | A17L | Mouse IgG | Variola (Smallpox) Virus | WB (Other applications need to be tested) |
| MPYF-1022-KX1382 | Anti-Vaccinia Virus (Smallpox Vaccine) A17L Monoclonal Antibody (MP-K1316) (Mouse IgG) | A17L | Mouse IgG | Vaccinia Virus (Smallpox Vaccine) | WB (Other applications need to be tested) |
| MPYF-0822-YF116 | Anti-Monkeypox Virus A17L Monoclonal Antibody (MP-W81) (Mouse IgG) | A17L | Mouse IgG | Monkeypox Virus | WB (Other applications need to be tested) |
| Cat# | Product Name | Species | Expression System | Target Protein | Protein Length |
|---|---|---|---|---|---|
| MPYF-0922-KX777 | Magic™ Variola (Smallpox) Virus (India-1967, Ind5) A17L Recombinant Protein | Variola (Smallpox) Virus | Based on specific requirements | A17L | Full length |
| MPYF-0722-KX230 | Magic™ Monkeypox virus (Zaire-96-I-16) A17L Recombinant Protein | Monkeypox virus | Based on specific requirements | A17L | Full Length |
| MPYF-1022-KX766 | Magic™ Squirrel Parapoxvirus (Red squirrel UK) A17L Recombinant Protein | Squirrel Parapoxvirus | Based on specific requirements | A17L | Full Length |
| MPYF-0922-KX517 | Magic™ Vaccinia Virus (Smallpox Vaccine) (Western Reserve) A17L Recombinant Protein | Vaccinia Virus (Smallpox Vaccine) | Based on specific requirements | A17L | Full length |
| Cat# | Product Name | Species | Target |
|---|---|---|---|
| MPYF-0722-KX1432 | Monkeypox virus, A17L-F | Monkeypox virus | A17L |
| MPYF-0722-KX1623 | Monkeypox virus, A17L-R | Monkeypox virus | A17L |
| Cat# | Product Name | Species | Target |
|---|---|---|---|
| MPYF-0722-KX1241 | Magic™ Monkeypox virus A17L Expression Plasmid | Monkeypox virus | A17L |
Creative Biolabs employs cutting-edge platforms and proprietary technologies to ensure the success of A17L antibody development:
Rapid screening and identification of A17L-specific antibody candidates.
Precise isolation and characterization of naturally occurring antibodies.
Reliable production of monoclonal antibodies.
Accelerated candidate validation through advanced automation.
The applications of A17L-specific antibodies including:
Creative Biolabs provides professional A17L antibody development services. Choosing us ensures:
Quality is at the core of all our services. Creative Biolabs applys rigorous quality control measures at each stage of the A17L antibody development process. These include:
Creative Biolabs offers a broad range of animal models for immunization, including mice, rats, rabbits, and other species, based on your specific project needs. Our team provides guidance on the most suitable model to achieve your research goals, taking into account factors like antibody type, expected yield, and downstream applications.
Absolutely. Creative Biolabs offers antibody conjugation services to enable the use of A17L antibodies in specific applications such as flow cytometry, immunofluorescence, or ELISA. Common conjugations include:
Our team ensures that conjugation processes maintain antibody integrity and performance, optimizing them for your intended use.
We DO NOT PROVIDE ANY PRODUCTS OR SERVICES DIRECTLY TO PATIENTS. All of our products are for Research Use Only (RUO), NOT intended for diagnostic, therapeutic, or clinical use.